| Literature DB >> 29021931 |
Abstract
There are very few studies for combinatorial library design and high throughput screening of 4-anilinoquinoline antimalarial compounds having activities against parasitic strain of P. falciparum. Therefore, an attempt has been made in the present paper to design potent lead compounds in this congener utilizing quantitative structure activity relationship utilizing theoretical molecular descriptors. QSAR models for a series of 4-anilinoquinolines considering various theoretical molecular descriptors including topological, constitutional, geometrical, functional group and atom-centered fragments has been carried out by stepwise forward-backward variable selections assimilating multiple linear regression (MLR) methods showing the topological indices contribute maximum impact on parasitic P. falciparum strain. A combinatorial library of 2160 compounds has been generated and finally, 16 compounds were screened through high throughput screening as promising 4-anilinoquinoline antimalarial hits based on their predicted activities utilizing topological descriptor based validated QSAR model. Highly predicted active compounds were then undergone for pharmacophore modeling to predict mode of binding and to optimize leads having greater affinity towards malarial P. falciparum parasitic strain.Entities:
Keywords: 4-Anilinoquinolines; Combinatorial library generation; Pharmacophore; QSAR; Topological indices; Virtual screening
Year: 2015 PMID: 29021931 PMCID: PMC5590512 DOI: 10.1186/s40064-015-1593-3
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Biological activity data
Scaffold and possible substituents attached to develop the virtual library
Impact of descriptors on biological activity
| Descriptor class | R2 | Rcv2 |
|---|---|---|
| Topological | 0.870 | 0.810 |
| Functional group + atom centered fragments | 0.812 | 0.744 |
| Constitutional + molecular property | 0.784 | 0.644 |
| 3d + geometrical | 0.713 | 0.634 |
Topological indices based training QSAR model and interpretation of the modeled descriptors
| Validated training QSAR model | |
|---|---|
|
|
Predicted activity for the test set molecules
| Compound number | Observed activity | Predicted activity |
|---|---|---|
| 3 | 0.8681 | 0.754 |
| 8 | 1.3516 | 0.535 |
| 13 | 1.2933 | 1.362 |
| 17 | −0.1614 | 0.153 |
| 22 | 1.8097 | 1.234 |
| 35 | 2.301 | 1.606 |
| 43 | 2.1249 | 1.909 |
| 46 | 1.9393 | 2.031 |
| 47 | 2.2596 | 2.051 |
| 48 | 1.886 | 2.013 |
| 57 | 2.0706 | 1.982 |
| 62 | 2.130 | 2.023 |
Fig. 1Observed versus predicted activities of the test molecules
Top 16 highly predicted active compounds along with their predicted biological activity
Fig. 2Pharmacophore of amodiaquine (AQ)
Comparative pharmacophoric 3D features for AQ (lead) and top 16 predicted active congeners
| Compound ID | Pharmacophoric 3D features predicted by our models | |||||||
|---|---|---|---|---|---|---|---|---|
| Quinoline | N1 | 4-amino | 4-anilino benzene | R7 | R′3 | R′4 | R′5 | |
| AQ (Lead) | H; AR | HBA | HBD | AR | H | PI; H | HBA; HBD | - |
| 659 | H; AR | HBA | HBD | AR | H; HBA | PI | HBA;HBD | PI |
| 649 | H; AR | HBA | HBD | AR | H; HBA | PI | HBD | PI |
| 289 | H; AR | HBA | HBD | AR | H | PI | HBD | PI |
| 299 | H; AR | HBA | HBD | AR | H | PI | HBA;HBD | PI |
| 1029 | H; AR | HBA | HBD | AR | H | PI | HBA;HBD | PI |
| 1009 | H; AR | HBA | HBD | AR | H | PI | HBD | PI |
| 1019 | H; AR | HBA | HBD | AR | H | PI | HBA;HBD | PI |
| 403 | H; AR | HBA | HBD | AR | H; HBA | PI | HBD | PI |
| 454 | H; AR | HBA | HBD | AR | H; HBA | PI; H; H | HBA;HBD | PI; H; H |
| 413 | H; AR | HBA | HBD | AR | H; HBA | PI | HBA;HBD | PI |
| 464 | H; AR | HBA | HBD | AR | H; HBA | PI; H; H | HBA;HBD | PI; H; H |
| 444 | H; AR | HBA | HBD | AR | H; HBA | PI; H; H | HBD | PI; H; H |
| 340 | H; AR | HBA | HBD | AR | H | AR; H; H | HBA;HBD | AR; H; H |
| 597 | H; AR | HBA | HBD | AR | H; HBA | PI; H; H | HBA; H; AR | PI; H; H |
| 577 | H; AR | HBA | HBD | AR | H; HBA | PI; H; H | HBA;HBD | PI; H; H |
| 43 | H; AR | HBA | HBD | AR | H | PI | HBD | PI |
H hydrophobicity, AR aromaticity, HBD hydrogen bond donor, HBA hydrogen bond acceptor, PI positive ionization
Fig. 3Pharmacophore models of selected highly active virtual hits
Fig. 4Pharmacophore models of selected highly active virtual hits